Kerstin Mayer1, Friederike Blume2, Sarah Nicole Wyckoff3, Luisa Leonie Brokmeier4, Ute Strehl5. 1. Institute for Medical Psychology and Behavioural Neurobiology, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany. Electronic address: kerstin.mayer@uni-tuebingen.de. 2. LEAD Graduate School, University of Tübingen, Gartenstraße 29, 72074 Tübingen, Germany. Electronic address: friederike.blume@uni-tuebingen.de. 3. Institute for Medical Psychology and Behavioural Neurobiology, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany; SenseLabs, 1918 N. Higley Rd., Mesa, AZ 85205, USA. Electronic address: wyckoffsarah@gmail.com. 4. Institute for Medical Psychology and Behavioural Neurobiology, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany. Electronic address: luisa.brokmeier@student.uni-tuebingen.de. 5. Institute for Medical Psychology and Behavioural Neurobiology, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany. Electronic address: ute.strehl@uni-tuebingen.de.
Abstract
OBJECTIVE: Attention Deficit-/Hyperactivity Disorder (ADHD) has been treated successfully in children with neurofeedback (NF). In this study, for the first time NF is investigated in adults with ADHD. To answer the question of specificity the relationship between treatment outcome and self-regulation ability is assessed. METHODS: Twenty-four participants underwent 30 sessions of slow cortical potential NF. Measurements of ADHD and comorbid symptoms, as well as neurophysiological data (reaction time (RT) and RT variability (RTV) and contingent negative variation (CNV)) were performed before and after treatment, and again six months after sessions were completed. Participants were categorized into self-regulation learners and non-learners. RESULTS: Significant improvements on all symptom scales were observed with medium to large effect sizes after treatment and six months post treatment. RT and RTV decreased significantly and there was a trend for an increased CNV. Half of the participants successfully learned to regulate their brain activity. In the long-term, symptoms in the group of learners improved more than in non-learners with large effect sizes. CONCLUSION: NF is effective in treating adult ADHD long-term. The impact of self-regulation ability and possible unspecific effects still require further investigation. SIGNIFICANCE: This study is the first to investigate the effects of NF in adults with ADHD, relating clinical outcome to self-regulation performance.
OBJECTIVE:Attention Deficit-/Hyperactivity Disorder (ADHD) has been treated successfully in children with neurofeedback (NF). In this study, for the first time NF is investigated in adults with ADHD. To answer the question of specificity the relationship between treatment outcome and self-regulation ability is assessed. METHODS: Twenty-four participants underwent 30 sessions of slow cortical potential NF. Measurements of ADHD and comorbid symptoms, as well as neurophysiological data (reaction time (RT) and RT variability (RTV) and contingent negative variation (CNV)) were performed before and after treatment, and again six months after sessions were completed. Participants were categorized into self-regulation learners and non-learners. RESULTS: Significant improvements on all symptom scales were observed with medium to large effect sizes after treatment and six months post treatment. RT and RTV decreased significantly and there was a trend for an increased CNV. Half of the participants successfully learned to regulate their brain activity. In the long-term, symptoms in the group of learners improved more than in non-learners with large effect sizes. CONCLUSION: NF is effective in treating adult ADHD long-term. The impact of self-regulation ability and possible unspecific effects still require further investigation. SIGNIFICANCE: This study is the first to investigate the effects of NF in adults with ADHD, relating clinical outcome to self-regulation performance.
Authors: Simon H Kohl; David M A Mehler; Michael Lührs; Robert T Thibault; Kerstin Konrad; Bettina Sorger Journal: Front Neurosci Date: 2020-07-21 Impact factor: 5.152
Authors: Sandra Fielenbach; Franc C L Donkers; Marinus Spreen; Harmke A Visser; Stefan Bogaerts Journal: Front Psychiatry Date: 2018-01-25 Impact factor: 4.157
Authors: Analucia A Alegria; Melanie Wulff; Helen Brinson; Gareth J Barker; Luke J Norman; Daniel Brandeis; Daniel Stahl; Anthony S David; Eric Taylor; Vincent Giampietro; Katya Rubia Journal: Hum Brain Mapp Date: 2017-03-25 Impact factor: 5.038
Authors: Kayleah M Groeneveld; Anna M Mennenga; Robert C Heidelberg; Rachel E Martin; Rachel K Tittle; Kyle D Meeuwsen; Linda A Walker; Elyse K White Journal: Appl Psychophysiol Biofeedback Date: 2019-12